Overview

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This study will assess the effectiveness and safety of different combination antihypertensive treatments in patients with severe hypertension
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Valsartan